Th17/IL-17, Immunometabolism of Psoriasis and Metabolic Disease | Paolo Gisondi, MD | Italy
Автор: International Psoriasis Council
Загружено: 2026-01-26
Просмотров: 8
Описание: IPC Councilor, Dr. Paolo Gisondi, examines IL-17 signaling at the intersection of psoriatic inflammation and metabolic disease, reviewing how IL-17 drives systemic inflammation and metabolic dysregulation. He summarizes clinical and real-world data showing that IL-17 inhibitors are metabolically neutral, reduce systemic inflammation, and may modestly benefit vascular health, though definitive cardiometabolic risk reduction remains unproven.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: